Hangzhou Huasai Biomedicine Co., Ltd.
PrivateLast Round
Series A
Dec 28, 2023
Company Overview
Hangzhou Huasai Biomedicine Co., Ltd. is a biopharmaceutical company that develops innovative cell therapies, specifically focusing on tumor-infiltrating lymphocyte (TIL) therapies for the treatment of solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hangzhou Huasai Biomedicine Co., Ltd. Comparables
Compare Hangzhou Huasai Biomedicine Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Suzhou Lanma Medical Technology Co., Ltd. | 90% | |
| Grit Biotherapeutics | 89% | |
| Shanghai Juncell Therapeutics Co., Ltd. | 89% |
Hangzhou Huasai Biomedicine Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 28, 2023 | ||||
| Pre Seed | Dec 21, 2021 |
Hangzhou Huasai Biomedicine Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Letong Capital | Series A |
| 澳银资本 | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 28, 2023
Raised Series A with Letong Capital and Qingdao Beian Holdings.
Hangzhou Huasai Biomedicine Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Hangzhou Huasai Biomedicine Co., Ltd.'s valuation, stock price, and market status.
Is Hangzhou Huasai Biomedicine Co., Ltd. a public or private company?
Hangzhou Huasai Biomedicine Co., Ltd. is a private company.
What is the current stock price of Hangzhou Huasai Biomedicine Co., Ltd.?
Hangzhou Huasai Biomedicine Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is Hangzhou Huasai Biomedicine Co., Ltd. worth (valuation)?
Valuation information for Hangzhou Huasai Biomedicine Co., Ltd. is not publicly available.
Can I buy Hangzhou Huasai Biomedicine Co., Ltd. stock?
Hangzhou Huasai Biomedicine Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Hangzhou Huasai Biomedicine Co., Ltd.'s last funding round?
Hangzhou Huasai Biomedicine Co., Ltd.'s most recent funding round was Series A on December 28, 2023.
Who are the main investors in Hangzhou Huasai Biomedicine Co., Ltd.?
Key investors in Hangzhou Huasai Biomedicine Co., Ltd. include 澳银资本.
Will Hangzhou Huasai Biomedicine Co., Ltd. IPO soon?
No public IPO plans have been announced for Hangzhou Huasai Biomedicine Co., Ltd..
How can I track Hangzhou Huasai Biomedicine Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Hangzhou Huasai Biomedicine Co., Ltd.'s secondary market activity and sign up for updates.